Estrogen receptor alpha is expressed in mesenteric mesothelial cells and is internalized in caveolae upon Freund's adjuvant treatment

PLoS ONE

Volumn 8, Issue 11, 2013, Pages

  Balogh, Petra ^a   Szabó, Arnold ^a   Katz, Sándor ^a   Likó, István ^b   Patócs, Attila ^c   L Kiss, Anna ^a  

^a SEMMELWEIS UNIVERSITY   (Hungary)

^b Pharmacology and Drug Safety Research   (Hungary)

^c HSA SE Lendület Hereditary Endocrine Tumors Research Group   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

CAVEOLIN 1; ESTROGEN RECEPTOR ALPHA; FREUND ADJUVANT; PROTEIN BINDING;

ANIMAL; CAVEOLA; DRUG EFFECTS; EPITHELIAL MESENCHYMAL TRANSITION; EPITHELIUM CELL; FEMALE; GENETICS; IMMUNOHISTOCHEMISTRY; MALE; MESENTERY; METABOLISM; RAT; ULTRASTRUCTURE;

ANIMALS; CAVEOLAE; CAVEOLIN 1; EPITHELIAL CELLS; EPITHELIAL-MESENCHYMAL TRANSITION; ESTROGEN RECEPTOR ALPHA; FEMALE; FREUND'S ADJUVANT; IMMUNOHISTOCHEMISTRY; MALE; MESENTERY; PROTEIN BINDING; RATS;

EID: 84893847182     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0079508     Document Type: Article

References (69)

1. Kalluri R, Weinberg RA (2009) The basics of epithelial-mesenchymal transition. J Clin Invest 119: 1420-28.
2. Lee MJ, Dedhar S, Kalluri R, Thompson WE (2006) The epithelial- mesenchymal transition: new insights in signaling, development, and disease. J Cell Biol 172: 973-981
3. Yanez-Mó M, Lara-Pezzi E, Selgas R, Ramírez-Hueasca M, Domingez-Jimenez C, et al. (2003) Peritoneal Dialysis and Epithelial-to- Mesenchymal Transition of Mesothelial Cells. N Eng J Med 348: 403-413
4. Sodek KL, Murphy KJ, Brown TJ, Ringuette MJ (2012) Cell-cell and cell-matrix dynamics in intraperitoneal cancer metastasis. Cancer Metastasis Rev 31: 397-414
5. Strutz F, Zeisberg M, Ziyadeh FN, Yang CQ, Kalluri R, et al. (2002) Role of basic fibroblast growth factor-2 in epithelial-mesenchymal transformation. Kidney Int 61: 1714-28. (Pubitemid 34437925)
6. Massagué J (1998) TGF-β signal transduction. Annu Rev Biochem 67: 753-91.
7. Zavadil J, Böttinger EP (2005) TGF-β and epithelial-to- mesenchymal transitions. Oncogene 24: 5764-5774
8. Derynck R, Zhang YE (2003) Smad-dependent and Smad-independent pathways in TGF-β family signalling. Nature 424: 577-584 (Pubitemid 37280136)
9. Ye Y, Xiao Y, Wang W, Yeasley K, Gao JX, et al. (2010) ERalpha signaling through slug regulates E-cadherin and EMT. Oncogene 29: 1451-1462
10. Planas-Silva MD, Waltz PK (2007) Estrogen promotes reversible epithelial-to-mesenchymal-like transition and collective motility in MCF-7 breast cancer cells. J Steroid Biochem Mol Biol104: 11-21. (Pubitemid 46412987)
11. Guttila IK, Adams BD, White BA (2012) ERα, microRNAs, and the epithelial-mesenchymal transition in breast cancer. Trends Endocrinol Metab 23: 73-82
12. Tsai MJ, O'Malley BW (1994) Molecular mechanism of action of steroid/thyroid receptor superfamily members. Ann Rev Biochem 63: 451-486
13. Beato M, Herrlich P, Schutz G (1995) Steroid hormon receptors: many actors insearch of a plot. Cell 83: 851-857 (Pubitemid 26006527)
14. Driggers P, Segards JH (2002) Estrogen action and cytoplasmic signaling pathways. Part II: The role of growth factors and phosphorylation in estrogen signaling. Trends Endocrinol Metab 13: 422-427
15. Levin ER (2002) Cellular functions of plasma membrane estrogen receptors. Steroids 67: 471-475
16. Hall JM, Couse JF, Korach K (2001) The multifaceted mechanisms of estradiol and estrogen receptor signaling. J Biol Chem 276: 36869-36872
17. Razandi M, Pedram A, Greene GL, Levin ER (1999) Cell membrane and nuclear estrogen receptors derive from a single transcript: studies of ERα and ERβ expressed in CHO cells. Mol Endocrinol 13: 307-319 (Pubitemid 29068005)
18. Pietras R, Szego CM (1977) Specific binding sites for oestrogen at the outer surfaces of isolated endometrial cells. Nature 265: 69-72 (Pubitemid 8004314)
19. Migliaccio A, Di Domenico M, Castoria G, de Falco A, Bontempo B, et al. (1996) Tyrosine kinase/p21 ras/MAP-kinase pathway activation by estradiol-receptor complex in MCF-7 cells. EMBO J 15: 1292-1300
20. Song RX, Santen RJ (2006) Membrane initiated estrogen signaling in breast cancer. Biol Reprod 75: 9-16 (Pubitemid 43946335)
21. Song RX, Zhang Z, Santen RJ (2005) Estrogen rapid action via protein complex formation involving ERalpha and Src. Trends Endocrinol Metab 16: 347-353 (Pubitemid 41338739)
22. Simoncini T, Mannella P, Fornari L, Caruso A, Varone G, et al. (2004) Genomic and non-genomic effects of estrogens on endothelial cells. Steroids 69: 537-542 (Pubitemid 39013484)
23. Levin ER (2009) Plasma membrane estrogen receptors. Trends Endocrinol Metab 20: 477-82
24. Ito I, Hanyu A, Wayama M, Goto N, Katsuno Y, et al. (2010) Estrogen inhibits transforming growth factor β signaling by promoting Smad2/3 degradation. J Biol Chem285: 14747-55.
25. Band AM, Laiho M (2011) Crosstalk of TGF-β and estrogen receptor signaling in breast cancer. J Mammary Gland Biol Neoplasia 16: 109-115
26. Katz S, Balogh P, Nagy N, Kiss AL (2012) Epithelial-to-mesenchymal transition induced by Freund's adjuvant treatment in rat mesothelial cells: a morphological and immunocytochemical study. Path Onc Research 18: 641-649
27. Katz S, Balogh P, Kiss AL (2011) Mesothelial cells can detach from the mesentery and differentiate into macrophage-like cells. APMIS 119: 782-793
28. Kiss AL, Kittel A (1995) Early endocytotic steps in elicited macrophages: omega-shaped plasma membrane vesicles at their cell surface. Cell Biol Int 19: 527-538
29. Murphy AJ, Guyre PM, Wira CR, Piolo PA (2009) Estradiol regulates expression of estrogen receptor ERα46 in human macrophages. PLoS ONE 4: e5539
30. Straub RH (2007) The complex role of estrogens in inflammation. Endocr Rev. 28: 521-574
31. ARAC Guidlines for the use of Adjuvants in research. NIH Intramural Guidlines 2010
32. Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248-54
33. Slot JW, Geuze HJ (2007) Cryosectioning and immunolabeling. Nat Prot 2: 2480-2491
34. Douvdevani A, Rapoport J, Konforty A, Argov S, Ovnat A, et al. (1994) Human peritoneal mesothelial cells synthesize IL-1α and β. Kidney Int 46: 993-1001 (Pubitemid 24319936)
35. Topley N, Jörres A, Luttmann W, Petersen MM, Lang MJ, et al. (1993) Human peritoneal mesothelial cells synthesize interleukin-6: Induction by IL-1β and TNFα. Kidney Int 43: 226-233 (Pubitemid 23167470)
36. Offner FA, Obrist P, Stadlmann S, Feichtinger H, Klinger P, et al. (1995) IL-6 secretion by human peritoneal mesothelial and ovarian cancer cells. Cytokine 7: 542-547
37. Feldmann M, Saklatvala J (2001) Proinflammatory cytokines. In: Oppenheim JJ & Feldman M, eds. Cytokine Reference. New York: Academic Press 291-305
38. Moustakas A, Heldin CH (2005) Non-Smad TGF-β signals. J Cel Sci 118: 3573-3584
39. Lee MK, Pardoux C, Hall MC, Lee PS, Warburton D, et al. (2007) TGF-β activates Erk MAP kinase signaling through direct phosphorylation of ShcA. EMBO J 26: 3957-3967 (Pubitemid 47367487)
40. Engel M, McDonnell MA, Law BK, Moses HL (1999) Interdependent Smad and JNK signaling in transforming growth factor-β-mediated transcriptioin. J Biol Chem 274: 37413-37420
41. Kamaraju AK, Roberts AB (2005) Role of Rho/ROCK and p38 MAP kinase pathways in transforming growth factor-β-mediated Smad-dependent growth inhibition of human breast carcinoma cells in vivo. J Biol Chem 280: 1024-1036
42. Futcher B, Latter GI, Monardo P, McLaughlin CS, Garrels JI (1999) A sampling of the yeast proteome. Mol Cell Biol 19: 7357-7368. (Pubitemid 29493399)
43. Griffin TJ, Gygi SP, Ideker T, Rist B, Eng J, et al. (2002) Complementary profiling of gene expression at the transcriptome and proteome levels in Saccharomyces cerevisiae. Mol Cell Proteomics 1: 323-333.
44. Gygi SP, Rochon Y, Franza BR, Aebersold R (1999) Correlation between protein and mRNA abundance in yeast. Mol Cell Biol 19: 1720-1730. (Pubitemid 29098230)
45. Ideker T, Thorsson V, Ranish JA, Christmas R, Buhler J, et al. (2001) Integrated genomic and proteomic analyses of a systematically perturbed metabolic network. Science 292: 929-934 (Pubitemid 32422490)
46. Schmidt MW, Houseman A, Ivanov AR, Wolf DA (2007) Comparative proteomic and transcriptomic profiling of the fission yeast Schizosaccharomyces pombe. Mol Syst Biol 3: 79
47. Washburn MP, Koller A, Oshiro G, Ulaszek RR, Plouffe D, et al. (2003) Protein pathway and complex clustering of correlated mRNA and protein expression analyses in Saccharomyces cerevisiae. Proc Natl Acad Sci USA 100: 3107-3112 (Pubitemid 36356547)
48. Jayapal KP, Philp RJ, Kok YJ, Yap MGS, Sherman DH, et al. (2008) Uncovering genes with devergent mRNA-protein dynamics in Streptomyces coelicolor. PLoS ONE 3: e2097
49. Guttilla IK, Phoenix KN, Hong X, Tirnauer JS, Claffey KP, et al. (2012) Prolonged mammosphere culture of MCF-7 cells induces an EMT and repression of the estrogen receptor by microRNAs. Breast Cancer Res Treat 132: 75-85
50. Razandi M, Oh P, Pedram A, Schnitzer J, Levin ER (2002) ERs associate with and regulate the production of caveolin: implications for signaling and cellular actions. Mol Endocrinol 16: 100-115 (Pubitemid 34044501)
51. Lisanti MP, Scherer P, Tang ZL, Sargiacomo M (1994) Caveolae, caveolin and caveolin-rich membrane domains: a signalling hypothesis. Trends Cell Biol4: 231-35. (Pubitemid 24190653)
52. Couet J, Li S, Okamoto T, Scherer P, Lisanti MP (1997) Molecular and cellular biology of caveolae: Paradoxes and plasticities. Trends Cardiovasc Med7: 103-10. (Pubitemid 27250704)
53. Parton RG, Simons K (2007) The multiple faces of caveolae. Nat Rev Mol Cell Biol8: 185-94.
54. Lisanti MP, Tang Z, Scherer PE, Kübler E, Koleske AJ, et al. (1995) Caveolae, transmembrane signalling and cellular transformation. Mol Membr Biol 12: 121-124
55. Kurzchalia TV, Parton RG (1999) Membrane microdomains and caveolae. Curr Opin Cell Biol 11: 424-431 (Pubitemid 29396787)
56. Di Gugliemo GM, le Roy C, Goodfellow AF, Wrana JL (2003) Distinct endocytic pathways regulate TGF-β receptor signalling and turnover. Nat Cell Biol 5: 410-421 (Pubitemid 36592263)
57. Barbiere MA, Roberts RL Gumusboga A, Highfield H, Alvarez-Domingez C, et al. (2000) Epidermal growth factor and membrane trafficking. EGF receptor activation of endocytosis requires Rab5a. J Cell Biol 151: 539-550
58. Liu J, Oh P, Horner T, Rogers RA, Schnitzer JE (1997) Organized endothelial cell surface signal transduction in caveolae distinct from glycosylphosphatidylinositol-anchored protein microdomains. J Biol Chem 272: 7211-7222 (Pubitemid 27166428)
59. Parton RG, del Pozo MA (2013) Caveolae as plasma membrane sensors, protectors and organizers. Nat Rev Mol Cell Biol 14: 98-112
60. Christensen A, Micevych P (2012) CAV1 siRNA reduces membrane estrogen receptor-alpha levels and attenuates sexual receptivity.Endocrinology153: 3872-7
61. Li S, Okamoto T, Chun M, Sargiacomo M, Casanova JE, et al. (1995) Evidence for a regulated interaction between heterotrimeric G proteins and caveolin. J Biol Chem 270: 15693-15701
62. Li S, Couet J, Lisanti MP (1996) Src tyrosine kinases, Galpha subunits, and HRas share a common membrane-anchored scaffolding protein, caveolin. Caveolin binding negatively regulates the auto-activation of Src tyrosine kinases. J Biol Chem 271: 29182-29190 (Pubitemid 26382628)
63. Song RXD, Robert A, McPherson, Liana A, Yongde B, et al. (2002) Linkage of rapid estrogen action to MAPK activation by ERα-Shc association and Shc pathway activation. Mol Endocrinol 16: 116-12
64. Baran J, Mundy ID, Vasanji A, Parat MO (2007) Altered localization of H-Ras in caveolin-1-null cells is palmitoylation-independent. J Cell Commun Signal 1: 195-204
65. Schlegel A, Wang C, Katzenellenbogen BS, Pestell RG, Lisanti MP (1999) Caveolin-1 potentiates estrogen receptor α (ERα) signaling. J Biol Chem 274: 33551-33556
66. Adachi M, Fukuda M, Nishida E (2000) Nuclear export of MAP kinase (Erk) involves a MAP kinase kinase (MEK)-dependent active transport mechanism. J Cell Biol 148:849-856
67. Taub N, Teis D, Ebner HL, Hess MW, Huber LA (2007) Late endosomal traffic of epidermal growth factor receptor ensures spatial and temporal fidelity of mitogen-activated protein kinase signaling. Mol Biol Cell 18: 4698-4710 (Pubitemid 350246673)
68. Zehorai E, Yao Z, Plotnikov A, Seger R (2010) The subcellular localization of MEK and ERK-A novel nuclear translocation signal (NTS) paves a way to nucleus. Mol Cell Endocrinol 314: 213-220
69. Nada S, Hondo A, Kasai A, Koike M, Saito K, et al. (2009) The novel lipid raft adaptor p18 controls endosome dynamics by anchoring the MEK-ERK pathway to late endosomes. EMBO J 28: 477-489